• Category Archives Health Information Channels
  • NCLR and Peers for Progress Release Comprehensive Guides to Implementing Peer Support Programs

    2015-04-22_1701Peers for Progress, a program of the American Academy of Family Physicians Foundation, and the National Council of La Raza (NCLR) announced the release of two essential guides to enable accelerated implementation and scale-up of peer support programs in order to meet global healthcare challenges.

    The Peers for Progress Program Development Guide, is a comprehensive practical handbook representing the culmination of six years of intensive study and reporting by community health leaders across the globe. The guide serves as resource for potential and existing peer support program managers, providing step-by-step instruction on program planning, monitoring and evaluation, quality improvement, and sustainability. Healthcare providers and community leaders seeking to implement peer support programs will also find supporting documentation for their efforts in the form of a recently completed economic analysis report, which demonstrates the cost-effectiveness of implementing these programs and suggests an innovative payment model for peer support.

    “We are very excited to introduce the Peers for Progress Program Development Guide, which offers a menu of good practices and how-to resources for the healthcare community,” said Edwin B. Fisher, global director of Peers for Progress. “Existing program directors will benefit from the guidance on how to create and maintain the necessary frameworks for successful programs, and new managers will find the tools they need to demonstrate the real-world application of peer support programs in a variety of community settings.”

    The second resource, Mi Salud es Primero: A Model for Implementing a Promotores de Salud Program for Diabetes Self-Management in a Primary Care Setting, outlines an ideal design and implementation of a peer support program that could meet the needs of Spanish-speaking communities, which are often underserved and disproportionately affected by chronic illnesses such as diabetes. The guide draws on research from the Mi Salud es Primero/My Health Comes First program, targeted to urban, low-income primarily Latino adults with type 2 diabetes in Chicago, Illinois, which integrated promotores de salud or community health workers in a primary care setting.

    “NCLR finds that working with promotores de salud is highly effective in providing Latinos with the peer support they need to learn to eat healthier foods, exercise in a way that fits into their daily routines, and better follow their doctors’ instructions. These community health workers truly understand the challenges facing Latino patients and are able to share information in a way that is culturally and linguistically appropriate,” said A. Manuela McDonough, Associate Director, Institute for Hispanic Health, NCLR.

    Together with legacy data from the global studies, the Peers for Progress and NCLR guides strongly illustrate the crucial role peer support programming plays in closing gaps in healthcare.

    Copies of the guides may also be ordered by contacting info@peersforprogress.org or news@nclr.org

  • IBM, Coriell Life Sciences and CareKinesis Deliver Personalized Medicine to the Elderly Via the Cloud

    IBM, Coriell Life Sciences and CareKinesis Deliver Personalized Medicine to the Elderly Via the Cloud With SoftLayer, Healthcare Providers Can Better Analyze and Store Genetic Data in the Cloud to Improve Care IBM Corporation logo. (PRNewsFoto/IBM Corporation) LAS VEGAS, April 29, 2014 /PRNewswire/ — IBM (NYSE: IBM) today announced a collaboration with Coriell Life Sciences, a provider of genetic analysis at point of care, and CareKinesis, Inc., a Medication Risk Mitigation® pharmacy services firm, to bring personalized medicine to the elderly based on analyzing and storing genetic data in a secure cloud environment. Using SoftLayer, an IBM Company, Coriell Life Sciences, in collaboration with IBM and CareKinesis, is launching an initiative with Program for All Inclusive Care of the Elderly (PACE) clients, which cares for more than 5,000 seniors, helping to enhance medication safety by better understanding how high-risk individuals respond to specific medications and drug treatments. Currently, about three out of four older Americans have multiple chronic health conditions. Many of these patients are being treated with drugs that may work at odds with each other – the medication being used for one condition can actually make another condition worse. By 2030, one in five Americans will be over age 65. As a result, increasing healthcare costs and the healthcare system are just beginning to feel the burden. “The goal of personalized medicine is to individualize healthcare by using knowledge of patients’ health history, behaviors, environments, and, most recently, individual genetic makeup when making clinical decisions,” explained CareKinesis CEO Calvin H. Knowlton, BSPharm, MDiv, PhD. “This initiative will allow physicians to collaborate with CareKinesis pharmacists to access a patient’s genetic data to better understand what drug treatments are likely to be responded to, thus reducing medication-related problems and hospital visits, while decreasing the individual’s overall healthcare costs.” Overcoming the Big Data Challenge Working with genetic data presents massive challenges for both data storage and privacy protection. A whole human genome produces more than three billion points of data for a single individual. To address these issues, Coriell Life Sciences turned to a cloud storage service based on SoftLayer. In collaboration with IBM, Coriell Life Sciences built a scalable, cloud-based solution that safely and cost-effectively stores data in Coriell Life Sciences’ GeneVault. The GeneVault stores and manages millions of genetic data points. This data is then interpreted and shared with physicians through CareKinesis who layer additional medication management decision factors into a holistic tool for doctors within PACE organizations. Under the strict privacy controls of the interconnected CareKinesis and Coriell Life Sciences systems, physicians, healthcare providers and medical experts can access a patient’s genomic interpretation via any web connected device. For example, a cardiologist may consider prescribing a popular blood-thinning drug for an elderly man, but may be concerned about the potential for an adverse reaction. The PACE Team decides to conduct a test to assess if the participant will respond to the medication being considered. The test is run by swabbing the inside of the patient’s cheek to collect a tiny amount of genetic material, which goes to Coriell Life Sciences for testing. Results are analyzed and interpreted for their impact on drug response. The resulting report is then transmitted to the doctor giving guidance on whether the patient can safely use the drug. CareKinesis supports the process by making pharmacotherapy recommendations based on these results. The data can be used at any time it is needed in the future for pharmacotherapy prescribing decisions. “This approach of treating conditions ‘one at a time’ even if the treatments might conflict with one another has been common in medicine, in part because little information exists to guide practitioners in how to consider this problem, weigh alternatives and identify different options. Better understanding of an individual’s genome can lead to a more effective dosage regimen,” said Scott Megill, CEO of Coriell Life Sciences. “Now with the collaboration with IBM and CareKinesis, personalized medicine is presenting many new options to this growing demographic. The combination of cloud and mobile is making a healthcare ecosystem possible with the patient center stage, delivering health services more efficiently.” For more information on Coriell Life Sciences, visit http://www.coriell.com/ For more information on CareKinesis, visit http://www.carekinesis.com/ For more information on IBM Healthcare, visit www.ibm.com/industries/healthcare/ For more information about cloud offerings from IBM, visit http://www.ibm.com/cloud. For more information on IBM Impact, visit www.ibm.com/press/ibmimpact2014. For media inquiries, contact: Lizette Kodama IBM Media Relations 1 (646) 675-0750 lkodama@us.ibm.com

  • Groundbreaking new website launches, giving public access to measures of child wellbeing and equity throughout the U.S

    The Institute for Child, Youth and Family Policy (ICYFP) at Brandeis University’s Heller School for Social Policy and Management has launched a new online data and analysis tool, providing unprecedented insight into wellbeing and equity among the ever-more diverse child population in the United States.

    The site, diversitydatakids.org, allows users to create customized profiles, rankings and maps that make data visual and digestible. It also features a neighborhood-level child opportunity index, the first of its kind, developed in partnership with the Kirwan Institute for the Study of Race and Ethnicity at Ohio State University. This index allows users to view interactive maps of the opportunities that are available to children in their own neighborhoods; a story that is often strikingly different by race/ethnicity.

    In addition to providing this index and hundreds of standard data indicators broken down by race and ethnicity, this site generates unique, equity-focused indicators of known structural factors that influence disparities in healthy child development. It also allows users to drill down from the national level to smaller levels of geography such as metropolitan areas and school districts, and in some cases, down to the neighborhood level, providing pinpoint views of the often nuanced inequities present among children of various racial and ethnic groups.

    “The U.S. child population is increasingly racially and ethnically diverse, but unfortunately not all children have the same opportunities for healthy development,” said Dolores Acevedo-Garcia, Director of ICYFP and principal investigator of the diversitydatakids.org project. “Our future hinges on our ability to ensure equitable opportunities for children across all racial and ethnic groups to lead healthy, productive lives. We hope that our data will equip users to become more informed advocates for all children and especially for vulnerable children.”

    The U.S. philanthropy community is increasingly focused on data that promotes child advocacy through a lens of racial and ethnic equity. This project was originally funded with longtime support from the W.K. Kellogg Foundation, which also supported the development of diversitydatakids.org’s parent project (www.diversitydata.org), created in 2007.

    “Diversitydatakids.org is an invaluable resource for all communities working on racial equity. Census and other data that tell the story of our nation’s children will help refine the strategies the racial healing and racial equity movements use to accomplish this important work,” said Dr. Gail C. Christopher, Vice President of Program Strategy at the W.K. Kellogg Foundation. “We are proud of how this project has grown and evolved over the nine years of our partnership, and we are grateful for the tools it will continue to provide to foundation grantees in the years to come.”

    The diversitydatakids.org project has also received support from the Robert Wood Johnson Foundation (RWJF), which has prioritized building an inclusive and equitable culture of health for all Americans. The RWJF Commission for a Healthier America has recently released recommendations to improve health through early childhood education, community development, and promoting health outside the medical system. The data that diversitydatakids.org provides is closely aligned with and will help monitor the Commissions’ health recommendations.

    “We are working to build a culture of health for all Americans,” said Risa Lavizzo-Mourey, president and CEO of the Robert Wood Johnson Foundation, “a culture in which the health of our children is a matter of fact, not a matter of chance. The diversitydatakids.org project can be an indispensable tool in helping communities assess their health – and then take steps to improve it. RWJF is very proud to be able to support this big step forward for children and their health.”

    The launch of diversitydatakids.org is accompanied by the release of two fact sheets demonstrating how data can contribute to a more robust narrative around diversity and racial equity for children. The site will continue to release fact sheets and other content, sharing insights and providing examples of how data can be used by site visitors at any level of expertise.

    The site’s launch is the culmination of years of work at ICYFP on collecting the highest-quality data available on the U.S. child population and representing it in a way that tells a compelling story: child experiences in America vary drastically by race and ethnicity, often in ways that are systematically unfair and avoidable. The diversitydatakids.org team and ICYFP hope that the project will illuminate these issues for the public and provide a toolkit for other researchers, policymakers, and advocates to effect positive, lasting change for children in the U.S.

    For more information, visit www.diversitydatakids.org.

    The Institute for Child, Youth and Family Policy (CYFP)
    The Institute for Child, Youth and Family Policy (ICYFP) is located at the Heller School for Social Policy and Management at Brandeis University. The research team at ICYFP engages in both quantitative and qualitative research studies of children and families as well as the social policies that directly affect their wellbeing.

    The mission of ICYFP is to conduct and disseminate policy-relevant research on the wellbeing, health and development of children and their families. ICYFP seeks to understand the causes of inequities in children’s ability to achieve health and to offer program and policy solutions to alleviate these inequities. Research at ICYFP is strongly focused on understanding and quantifying disparities among children and their families by race/ethnicity, immigrant status, socioeconomic status, or disability status as they manifest themselves in opportunities for good health, education, and financial stability.

    Robert Wood Johnson Foundation
    For more than 40 years the Robert Wood Johnson Foundation has worked to improve the health and health care of all Americans. We are striving to build a national culture of health that will enable all Americans to live longer, healthier lives now and for generations to come. For more information, visit www.rwjf.org. Follow the Foundation on Twitter at www.rwjf.org/twitter or on Facebook at www.rwjf.org/facebook.

    W.K. Kellogg Foundation
    The W.K. Kellogg Foundation (WKKF), founded in 1930 as an independent, private foundation by breakfast cereal pioneer, Will Keith Kellogg, is among the largest philanthropic foundations in the United States. Guided by the belief that all children should have an equal opportunity to thrive, WKKF works with communities to create the conditions where vulnerable children can realize their full potential in school, work and life.

    The Kellogg Foundation is based in Battle Creek, Mich., and works throughout the United States and internationally, as well as with sovereign tribes. Special emphasis is paid to priority places where there are high concentrations of poverty and where children face significant barriers to success. WKKF priority places in the U.S. are in Michigan, Mississippi, New Mexico and New Orleans; and internationally, are in Mexico and Haiti. For more information, visit www.wkkf.org.

    SOURCE diversitydatakids.org

  • CVS/pharmacy Now Offers “Talking” Prescription Labels Through its Online Pharmacy for Individuals with Vision Impairments


    CVS/pharmacy announced today that it now provides ScripTalk talking prescription labels for prescriptions ordered for home delivery through its online pharmacy, CVS.com. The ScripTalk labels provide a safe and convenient way to access information on prescription labels for individuals who cannot read standard print. The ScripTalk labels are free to CVS.com pharmacy customers who are blind or visually impaired. Customers can also obtain a free ScripTalk reader from Envision America that will enable them to listen to the information on the ScripTalk label.

    “We are pleased to offer the ScripTalk service to our online pharmacy customers who are visually impaired,” said Josh Flum, Senior Vice President of Retail Pharmacy at CVS Caremark. “Enhancing access to important information about prescriptions is in keeping with our purpose of helping people on their path to better health.”

    Today’s announcement is the result of collaboration between CVS/pharmacy, the American Foundation for the Blind, American Council of the Blind and California Council of the Blind. These groups applauded CVS/pharmacy’s actions.

    “The lack of accessible labels on prescription drug containers puts people with vision loss at serious risk of medication mishaps,” said Paul Schroeder, Vice President of Programs & Policy at the American Foundation for the Blind. “We applaud CVS/pharmacy for taking steps to provide speech access to label information for customers with vision loss along with its willingness to evaluate methods to improve large print labels.”

    “This agreement is a positive step that allows for a greater level of privacy, safety, and independence for blind and visually impaired Americans of all ages who take prescription medications,” said Kim Charlson, president of the American Council of the Blind.

    “The California Council of the Blind applauds CVS’s willingness to offer access to the information on prescription medication labels. As a result of this initiative, persons who are blind or visually impaired who use CVS mail order to fill their prescription needs will have the same direct, and independent access to label information as do sighted customers,” stated Donna Pomerantz, President, California Council of the Blind.

    About CVS/pharmacy
    CVS/pharmacy, the retail division of CVS Caremark Corporation (NYSE: CVS), is America’s leading retail pharmacy with more than 7,600 CVS/pharmacy and Longs Drug stores. CVS/pharmacy is reinventing pharmacy to help people on their path to better health by providing the most accessible and personalized expertise, both in its stores and online at CVS.com. General information about CVS/pharmacy and CVS Caremark is available at http://info.cvscaremark.com.

    About American Council of the Blind (ACB) and California Council of the Blind (CCB)
    American Council of the Blind is a national consumer-based advocacy organization working on behalf of blind and visually impaired Americans throughout the country with members organized through seventy state and special interest affiliates. California Council of the Blind is the California affiliate of the ACB and is a statewide membership organization with 40 local chapters and statewide special interest associations. ACB and CCB are dedicated to improving the quality of life, equality of opportunity and independence of all people who have visual impairments. Their members and affiliated organizations have a long history of commitment to the advancement of policies and programs which will enhance independence for people who are blind and visually impaired. More information about ACB and CCB can be found by visiting www.acb.org and http://www.ccbnet.org.

    About American Foundation for the Blind
    The American Foundation for the Blind (AFB) is a national nonprofit that expands possibilities for people with vision loss. AFB’s priorities include broadening access to technology; elevating the quality of information and tools for the professionals who serve people with vision loss; and promoting independent and healthy living for people with vision loss by providing them and their families with relevant and timely resources. AFB is also proud to house the Helen Keller Archives and honor the over forty years that Helen Keller worked tirelessly with AFB. For more information visit AFB online.

    Media Contacts:

    Mike DeAngelis

    Kim Charlson
    President, American Council of the Blind

    Adrianna Montague-Devaud
    Chief Communications and Marketing Officer
    American Foundation for the Blind (AFB)
    Tel. (212) 502-7615

    SOURCE CVS/pharmacy







  • Nature Partner Journals, a new brand of open access journals

    Nature Publishing Group (NPG) is increasing its commitment to open science with the launch of the ‘Nature Partner Journal’ series. This high-quality, online-only subject specific portfolio of journals brings Nature’s reputation for impact and excellence to open access and publishing partnerships. The Nature Partner Journals will be characterized by landmark partnerships with institutions, foundations and academic societies. The home for Nature Partner Journals launched today at www.nature.com/npj.

    For each journal, NPG and its partner have jointly identified a need for a high-quality, peer-reviewed open access publication in high-impact and emerging or under-served fields.

    The first three titles of the Nature Partner Journal portfolio are:

    npj Primary Care Respiratory Medicine, http://www.nature.com/npjpcrm/ (with Primary Care Respiratory Society – UK and the International Primary Care Respiratory Group (IPCRG))
    npj Schizophrenia (with Schizophrenia International Research Society)
    npj Biofilms and Microbiomes (with Nanyang Technological University – NTU and Singapore Centre on Environmental Life Sciences Engineering – SCELSE)
    Nature Partner Journals will adopt a modified set of Nature editorial standards, with rigorous requirements for the training and appointment of Editors-in-Chief and continuous assessment of editorial quality against agreed key performance indicators.

    NPG, with strategic partner Frontiers, is a leading open access publisher. Together, they published 10,500 open access research papers in 2013, 51% of their combined research publication output for the year. All 63 NPG academic, society and partner publications have introduced open access options or are open access journals. For more information see URL (http://www.nature.com/libraries/open_access/index.html).

    Comment from NPG and its partners:

    “The Nature name is synonymous with our commitment to serving science & scientists, and with ambitions for high editorial standards,” says Philip Campbell, Editor-in-Chief of Nature and Nature Publishing Group. “Research is ever changing, and the Nature Partner Journals are one way in which we can meet the evolving needs of the research community. It is a pleasure to be collaborating in editorial expertise with our academic editors and partners.”

    “NPG is dedicated to both publishing the world’s leading research and to furthering open science,” says Martin Delahunty, Global Head of Partnership Journals, Open Research, NPG. “The Nature Partner Journals series enables us to share with our partners our strengths as a publisher of high-impact scientific research, and to increase the open access options we can make available to researchers.”

    “We are delighted to re-launch the Primary Care Respiratory Journal, the world’s only fully indexed academic journal devoted to primary care management of respiratory disease, in partnership with NPG as npj Primary Care Respiratory Medicine. We look forward to broadening the scope and appeal of the journal to both primary and secondary care professionals and academics,” Dr Patrick White, Chair, Primary Care Respiratory Society UK.

    “The International Primary Care Respiratory Group (IPCRG) very much looks forward to working alongside Primary Care Respiratory Society UK with Nature Publishing Group to raise the profile of respiratory research that reflects and is of value to real-life primary care. Our research and clinical networks reach primary care in all four continents and we believe that Nature’s global reach will stretch and strengthen them,” Associate Professor Niels Chavannes, President IPCRG.

    “We are very pleased to launch npj Schizophrenia in partnership with Nature Publishing Group. Our society represents leading researchers in schizophrenia from around the world. This journal coupled with Nature’s reputation and visibility will be a valuable resource in furthering our goals of advancing the creation and dissemination of new knowledge in this area,” John Kane, President, Schizophrenia International Research Society.

    “NTU’s partnership with NPG to establish a new open access journal npj Biofilms and Microbiomes is timely as the university ramps up its formation of a new Life Science and Biomedical research cluster. This new publication platform will bring together scientists studying the social behaviour of complex microbial communities across a wide disciplinary spectrum and covering natural, medical and industrial settings. NTU is always looking for such opportunities to play our part in pushing the frontiers of new, emerging fields,” said NTU President Professor Bertil Andersson.

    About Nature Publishing Group (NPG)
    Nature Publishing Group (NPG) is a publisher of high impact scientific information in print and online. NPG publishes journals, online databases and services across the life, physical, chemical and applied sciences.

    Focusing on the needs of scientists, Nature (founded in 1869) is the leading weekly, international scientific journal. NPG publishes a range of Nature research journals and Nature Reviews journals, and a range of prestigious academic and partner journals including society-owned publications. Online, nature.com provides over 8 million visitors per month with access to NPG publications and services, including news and comment from Nature, and the leading scientific jobs board Naturejobs.

    Part of the Nature Publishing Group family is Frontiers, a community-driven open-access publisher and research network. NPG and Frontiers work together to empower researchers to change the way science is communicated, through open access publication and open science tools. For more information on Frontiers, please go to www.frontiersin.org.

    Scientific American is at the heart of NPG’s consumer media division, meeting the needs of the general public. Founded in 1845, Scientific American is the oldest continuously published magazine in the US and the leading authoritative publication for science in the general media. Together with scientificamerican.com and 14 local language editions around the world it reaches over 5 million consumers and scientists. Other titles include Scientific American Mind and Spektrum der Wissenschaft in Germany.

    Throughout all its businesses NPG is dedicated to serving the scientific community and the wider scientifically interested general public. Part of Macmillan Science and Education, NPG is a global company with principal offices in London, New York and Tokyo, and offices in cities worldwide including Boston, San Francisco, Washington DC, Buenos Aires, Mexico City, Sao Paulo, Cairo, Dubai, Delhi, Mumbai, Hong Kong, Shanghai, Melbourne, Osaka, Seoul, Barcelona, Madrid, Basingstoke, Heidelberg, Munich and Paris. For more information, please go to www.nature.com.

    SOURCE Nature Publishing Group

    CONTACT: Rachel Scheer (Corporate Public Relations Manager), Nature Publishing Group, +1 212 451 8569, r.scheer@us.nature.com

  • Patients Nationwide Now Have Direct Access to Lab Test Results through Quest Diagnostics

    For the first time, Americans nationwide can directly access their personal laboratory data through Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services. Quest Diagnostics provides diagnostic information services to about 30% of American adults each year. Under a federal rule that goes into effect today, patients in all 50 states and the District of Columbia can now view test results from diagnostic information service providers without first being authorized by a physician. The rule issued by the U.S. Department of Health and Human Services amends the Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations to give patients (or their representatives) direct access to the patient’s laboratory test reports and eliminates an exception under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy Rule that prohibits an individual from accessing protected health information held by a CLIA-certified or CLIA-exempt laboratory. In combination, these changes require laboratories to provide patients access to their test reports. Patients can begin to view lab results today under the rule. Although laboratories may directly provide patients access to lab data beginning today under the rule, laboratory providers have until October 6, 2014 to comply with the rule’s requirement to provide lab data upon request nationwide. To help individuals receive access and track their lab and other health data, Quest Diagnostics has launched MyQuest® by Care360 at QuestDiagnostics.com/MyQuest, a secure patient portal that enables patients to view copies of their lab test reports from Quest Diagnostics. Quest Diagnostics is believed to be the first national commercial laboratory to facilitate direct patient access to lab information through a range of free channels which include a patient portal and mobile health app as well as traditional mail, fax and email. Quest has provided several channels for patients to request and receive their lab reports in select states where direct patient access had been allowed prior to the new federal rule. “Empowered patients are better patients. Because most healthcare decisions are based on diagnostic insights, patients who access their lab results may be more likely to have a well-informed dialogue about medical options with their physician,” said Jon R. Cohen, MD, senior vice president and chief medical officer, Quest Diagnostics. “Our MyQuest by Care360 patient portal represents the next phase of consumer healthcare – where people are empowered with information to play a greater role in their healthcare choices.” In addition to lab results, the portal enables users to view other health information, such as provider contact lists and medication reminders, and facilitates online appointment scheduling at any of Quest’s 2,200 patient service centers in the United States. MyQuest by Care360 Patient Portal and Care360 EHR Enable Physicians to Qualify for Meaningful Use Incentives The patient portal is also designed to help physicians that use the Quest Diagnostics Care360 Electronic Health Record (EHR) to qualify for the Centers for Medicare and Medicaid (CMS) EHR Incentive Program. Stage 2 of the MU program, which focuses on electronic engagement with patients, begins this year for providers that have participated in the program for at least two years. In order to meet the 2014 requirements of the CMS EHR Incentive Program, a physician must demonstrate that at least 50% of patients seen have online access to their health information (including lab results); 5% or more download, view or transmit their health information electronically; and 5% or more send the provider a secure electronic message. Physicians that use the Quest Diagnostics Care360 EHR can securely provide information and clinical summaries to patients who are registered on the MyQuest by Care360 portal, fulfilling the program requirements. “MyQuest by Care360 is about more than serving patients and providing them with a superior customer experience. We also designed the portal to help our thousands of Care360 EHR physician clients achieve Meaningful Use criteria for online patient engagement and other metrics of quality care,” said Catherine T. Doherty, senior vice president, Clinical Franchise Solutions, which includes Care360 products and services. “The result is a highly secure, interoperable solution that will help physician practices be more efficient as well as engage, educate and retain their patients.” Quest Renames Mobile Health App Additionally, Quest has renamed its mobile health app MyQuest by Care360. The app, which was launched in 2010, had been named Gazelle. Registered users of Gazelle will receive information about the transition via their app later this month. Use of the MyQuest by Care360 patient portal and mobile app, including access to lab results, is free. “Renaming our mobile health app MyQuest by Care360, the same name as the patient portal, underscores how both technologies are designed to work together to achieve the same goal: giving patients access to their Quest Diagnostics’ lab data,” said Dr. Cohen. Users of the MyQuest by Care360 mobile health app may request their lab results and access many of the same technologies found on the patient portal. The app is available for download on Android and Apple devices through the app stores or QuestDiagnostics.com/MyQuest. About Quest Diagnostics Healthcare IT Solutions Through its Care360 brand and suite of web-based healthcare IT solutions, Quest Diagnostics is a provider of healthcare information technology solutions that facilitate secure, flexible data access and management to help improve patient care and lower healthcare costs. The company’s solutions include the Care360 EHR and other Care360 connectivity solutions, which are used by more than 300,000 physician users in more than 90,000 locations, providing a network of affiliated physician users in local communities and across the country. Quest Diagnostics HIT solutions also include the MyQuest by Care360 patient portal and mobile health app for patients and physicians, and the award-winning ChartMaxx health document management solution. For more information, visit Care360.com or QuestDiagnostics.com/MyQuest. About Quest Diagnostics Quest Diagnostics is the world’s leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic information services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at QuestDiagnostics.com. Follow us at Facebook.com/QuestDiagnostics and Twitter.com/QuestDX. Quest, Quest Diagnostics, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks are the property of their respective owners. Quest Diagnostics Contacts: Wendy Bost (Media): 973-520-2800 Dan Haemmerle (Investors): 973-520-2900 Logo – http://photos.prnewswire.com/prnh/20130717/NY48934LOGO SOURCE Quest Diagnostics

  • ScienceDirect Content Now Available to MyScienceWork Users

    Elsevier, a world-leading provider of scientific, technical and medical information products and services, has announced its collaboration with scientific social network MyScienceWork on a pilot initiative to enable researchers to easily share and discover over 11 million articles through MyScienceWork.

    The pilot will allow MyScienceWork users to read, annotate and share articles from ScienceDirect within the MyScienceWork interface among each other. The articles on MyScienceWork will be presented the same way as users find them on ScienceDirect: full text published articles will be available to those affiliated with ScienceDirect subscribers and Open Access articles will be available to all.

    The pilot includes access to all of the content on ScienceDirect: over 12 million content items from over 2,200 journals and 26,000 book titles.

    “MyScienceWork works to make science easier and to help researchers save time. We want to provide researchers with wider access to publications. This includes promoting access to openly accessible content, but also developing new ways to easily reach publications from prestigious journals,” said Virginie Simon, CEO of MyScienceWork. “That is why, for users with institutional access, they can log in directly to the platform using their Science Direct access codes.”

    “Elsevier’s mission is to support the research community by developing the best and most efficient workflow solutions that will assist them in their important work,” said Olivier Dumon, Managing Director, Academic and Research Markets at Elsevier. “This project is a great example of how scientific social networks and publishers can collaborate to disseminate and share quality research publications We are excited to have found in MyScienceWork an ambitious and innovative provider to launch this new capability that will facilitate low-hassle, copyright compliant sharing of Elsevier content on the platform of choice of the user.”

    About MyScienceWork

    MyScienceWork is a social network based on the open access concept of providing researchers and the general public free access to scientific knowledge. Through its centralized communication platform, MyScienceWork offers more than 31 million publications, expert’s profiles, jobs offers, events and scientific news. The project is based on one major principle: associate content with visibility with a single click.

    Founded in 2010, MyScienceWork began as a popular science blog. Having built a solid community of researchers and lovers of science and forged partnerships with important institutions, the company launched its site in 2013. With the aim of internationalizing its activities, MyScienceWork set up operations in Luxembourg, looks for opening a subsidiary in Silicon Valley while maintaining its branch in Paris. MyScienceWork consists of a team of 15 people.

    About ScienceDirect

    ScienceDirect is home to almost one-quarter of the world’s peer-reviewed full-text scientific, technical and medical content. Over 15 million researchers, health care professionals, teachers, students and information professionals around the globe rely on ScienceDirect as a trusted source of nearly 2,200 journals, almost 900 serials and 25,000 book titles. ScienceDirect supports research and education with interactive elements in articles such as audio, video, graphs, tables and images, and offers tools so users can easily set alerts. Content on ScienceDirect also features embedded links to external datasets, including earth and environmental science data from PANGAEA, abstract and indexing data from Scopus and chemical reactions data from Reaxys. With almost 12 million content pieces available-including pre-publication release of articles and open access content from Elsevier journals-ScienceDirect is a premier platform for discovering the world of research.

    About Elsevier

    Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions – among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey – and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

    The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media contacts

    Harald Boersma
    Director Corporate Relations, Elsevier

    Laurence Bianchini
    CPO, MyScienceWork

    SOURCE Elsevier

  • Elsevier Announces the Launch of New Open Access Journal, Schizophrenia Research: Cognition

    Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.

    As a spin-off from companion journal Schizophrenia Research, which is one of the most recognized journals in the field, Schizophrenia Research: Cognition specializes in providing a forum on all aspects of cognition in schizophrenia, including clinical neuropsychology, neurocognition, social cognition, functional capacity, cognitive and social neuroscience, and aspects of everyday outcome as related to cognition. Articles that compare the influence of cognition and other influences on outcome in schizophrenia will also be published as will research on descriptive characteristics, genetic influences, pharmacological and non-pharmacological treatments, and neuroimaging correlates of these aspects of cognition.

    Schizophrenia Research: Cognition is an online-only journal and articles will be published rapidly after acceptance. The journal will publish the latest developments in the field, which currently are too often scattered among a host of other journals that do not always prominently feature these articles. Schizophrenia Research: Cognition will bring together research from other scientific disciplines including, neuroscience, genomics, and psychiatry.

    Dr. Philip D. Harvey, Editor-in-Chief of Schizophrenia Research: Cognition, explained, “The benefits of an international, specialized open-access journal focusing on cognition in schizophrenia will include broadening access to the rapidly changing developments in the field to scientists with limited access to subscription journals.”

    Published articles are now available on ScienceDirect and http://www.SchizResCognition.com

    For more information or to submit an article, go to:

    http://www.SchizResCognition.com or


    # # #

    About Elsevier

    Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions – among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey – and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

    The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media contact
    Natalie Hill-krasniqi

    SOURCE Elsevier

  • Nationwide Children’s Introduces NICVIEW Camera System to Connect NICU Newborns with their Families

    Nationwide Children’s Hospital, one of the largest and most comprehensive pediatric hospitals in the United States, just finished installing NICVIEW, which supports their philosophy of family-centered care in a unit where the length of stay is longer. NICVIEW, the NICU camera system, helps extend family-centered care by giving parents a virtual window to their newborns. Many of the babies in the NICU, ICC and SCN are born prematurely and are released within a few days. However, the length of stay for some on this unit at Nationwide Children’s can be months. While not a replacement for visiting in person, this password-protected system allows parents and extended family members 24/7 access to the new bundle of joy. To see the system in action at Nationwide, please check out the video http://bit.ly/1diwrTW

    “We are excited to install NICVIEW in such a prestigious children’s hospital as Nationwide,” said Dominic Foster, CTO of Healthcare Observation Systems, makers of the NICVIEW System. “It is the perfect solution to help parents and family members continue bonding with their child, even when they can’t be at the bedside.”

    NICVIEW Founders, Blake Rutherford, CEO, and Dominic Foster, CTO, have developed a safe, simple and secure system valued by families and clinical staff alike. A small camera mounted to the NICU bedside captures a live, secure password-protected video stream. Parents may choose whether or not they want to use the system and have exclusive control over the password, which may be distributed at their discretion to friends or family members. With the password, virtual visits with the newborn are made possible via any internet-enabled device, including all smart phones, tablets and computers. For more information about NICVIEW, visit www.nicview.net.

    Dominic Foster


  • Eye Matters: Facebook Page Rolls Out as a Book

    Is social media just about intriguing posts, zany photos, and fun memories? Or can it be used effectively to share health information to members around the world? Dr.Ashley Mulamoottil, an ophthalmologist who worked with Moorefield Eye Hospital in London and who returned 10 years ago to his hometown Kozhencherry, a tiny village in Kerala, India, asks this very question. Eye Matters, a compilation of postings from Dr.Ashley Mulamoottil’s Facebook page rolls out as a book next week lending credence to the efficacy and impact of social media. As the great-grandson of an Ayurvedic eye physician, Mulamoottil Mathan Mathai Vaidyar (1855-1934) who offered free treatment to patients, Dr.Ashley, who took up allopathic medicine, says social media helps him continue the tradition of offering free medical service at least by the act of sharing medical facts and treatments online. The responses to his posts are tremendous. Questions about eye health and potential treatments have started coming from all over the world, and in one year Dr.Ashley has became one of the most “liked” doctors on Facebook. In two years he is now covering a wide range of topics and offering information and solutions to eye related problems. “Because of requests from people, I started posting some medical videos. One day I posted a video of an unusual surgery that showed me removing a 20cm long worm (Loa Loa) from the eyes of a man. Within 48 hours of posting, the video got more than 20,000 shares. Nothing else convinced me as quickly and decisively of the power of social media,” says Dr.Ashley. “I got responses to my postings from more than 100 countries.” The widespread interest in health information that is being shared finally pushed Dr.Ashley to publish the collection of posts as a book. Eye Matters published by Invis Multimedia compiles selected postings from the last two years. The doctor surmises that this book is most likely first on health matters that has been put together entirely from FB posts. Dr.Ashley Mulamoottil is the first, and only, eye surgeon trained to perform Laser Cataract Surgery (Blade-free cataract surgery) in Kerala, India. In fact, he is considered the pioneer of blade-free surgeries in India. Anitha Invis Multimedia +914712311832 anitha@invis.in http://www.invismultimedia.com SOURCE Mulamoottil Eye Hospital